TipRanks
Go Ultimate55% OFF

Kymera Therapeutics (KYMR) Balance Sheet

Kymera Therapeutics Balance Sheet

Kymera Therapeutics's total assets for Q3 2026 were $1.77B, an increase of 7.40% from the previous quarter. KYMR total liabilities were $152.74M for the fiscal quarter, a 9.22% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.74B$ 978.03M$ 575.76M$ 603.13M$ 605.90M
$ 163.15M$ 142.42M$ 180.79M$ 112.98M$ 146.27M
$ 1.58B$ 835.62M$ 394.97M$ 490.15M$ 459.64M

Currency in USD

Kymera Therapeutics Debt to Assets

0800M1.6B2.4B0 %80 %160 %240 %LiabilitiesDebt to Assets20182019202020212022202320242025AssetsLiabilitiesDebt to Assets